Health ❯ Healthcare ❯ Weight Management

Obesity Treatment

Semaglutide Weight Loss Medications GLP-1 for Weight Loss Orforglipron GLP-1 Medications Oral Medications Weight-Loss Drugs Mounjaro Wegovy Pill GLP-1 Therapy Medication GLP-1 Injections Wegovy Weight Loss Benefits Ozempic Amylin Combination Therapy Tirzepatide GLP-1 Receptor Agonists Pharmaceutical Interventions Weight-loss Medications GLP-1 Therapies Orforglipron for Obesity Medications

4 ARTICLES

3w ago

Lilly Pulls Ahead in GLP‑1 Market as Novo Confronts U.S. Headwinds

Investor bets plus Lilly's oral pill Foundayo, factory expansion, larger R&D outlays have created a wide valuation gap that leaves Novo's recovery dependent on its pipeline and global reach.

5 ARTICLES

2mo ago

UK Approves Lilly’s Oral GLP‑1 Pill Foundayo

10 ARTICLES

3mo ago

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

5 ARTICLES

4mo ago

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

11 ARTICLES

5mo ago

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Obesity Treatment

Lilly Pulls Ahead in GLP‑1 Market as Novo Confronts U.S. Headwinds

UK Approves Lilly’s Oral GLP‑1 Pill Foundayo

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control